Needham Reiterates Buy on Evolus, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Serge Belanger has reiterated a Buy rating on Evolus (NASDAQ:EOLS), maintaining a $22 price target on the stock.

May 08, 2024 | 10:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Serge Belanger reaffirmed a Buy rating on Evolus, with a price target of $22, indicating a positive outlook on the stock.
The reiteration of a Buy rating by a reputable analyst, along with a maintained price target, suggests a strong vote of confidence in Evolus's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100